Benzinga | Jul 14, 2021 07:49AM EDT

SVB Leerink Maintains Outperform on Veracyte, Lowers Price Target to $55

SVB Leerink analyst Puneet Souda maintains Veracyte (NASDAQ:VCYT) with a Outperform and lowers the price target from $65 to $55.